- Category
- Small (2023-24)
- Udyam number
- UDYAM-RJ-17-0023415

Scarlet Formulation Private Limited
About Scarlet Formulation Private Limited
Data last updated:
Scarlet Formulation Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the hospital and clinical services segment of the healthcare sector. It was incorporated on 05 November 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2008PTC027686. Its GSTIN is 08AAMCS5130Q1ZQ (Rajasthan). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Kushal Pal Singh and Anil Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 62 Panchsheel Enclave Behind Hotel Clark Jln Marg, Jaipur, Rajasthan, India – 302017.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.85 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹9.33 Lakh (net margin 1.4%) and EBITDA of ₹29.54 Lakh (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 1% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹1.73 Cr on record.
Scarlet Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0023415). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Scarlet Formulation
Contact details
Scarlet Formulation Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address62 Panchsheel Enclave Behind Hotel Clark Jln Marg, Jaipur, Rajasthan, India – 302017
- IndustryHealthcare, Hospitals
To see the full contact details of Scarlet Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Scarlet Formulation is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
To see the full business activity and turnover split of Scarlet Formulation Private Limited, buy the company report.
Financials of Scarlet Formulation Private Limited
FY 2025 filings availableScarlet Formulation Private Limited reported revenue of ₹6.85 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 10% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 1%. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹29.54 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Scarlet Formulation Private Limited, buy the company report.
Board of directors of Scarlet Formulation Private Limited
Scarlet Formulation has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kushal Pal Singh Also directs: Devdhara Hospitalities Private Limited | Director | 25 Nov 2024 | 1 Years 11 Months | Current |
| Anil Kumar Also directs: Almo Impex (India) Private Limited, Almo Exports Private Limited, Anekant Pharmaceuticals Private Limited and 5 more | Director | 19 Oct 2024 | 2 Years 1 Months | Current |
| Ashwani Kumar Bhatia Also directs: Ruchi Pharma Distributors Private Limited, Medcart Anteka Private Limited, Well Life Healthcare Private Limited and 5 more | Director | 19 Oct 2024 | 2 Years 1 Months | Current |
Peer comparison
Scarlet Formulation Private Limited is compared with the 7 companies closest to it by revenue in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sahayog Hospital and Research Centre Pvt Ltd | ₹6.92 Cr (FY 2024) | 7.0% | Guna, Madhya Pradesh, India | |||
| Sushma Hospital and Research Centre Private Limited | ₹6.91 Cr (FY 2025) | 0.0% | Uttar Pradesh, India | |||
| G L Hospital Private Limited | ₹6.9 Cr (FY 2025) | 58.0% | Karaikkal, Puducherry, India | |||
| Scarlet Formulation Private Limitedthis company | ₹6.85 Cr (FY 2025) | ₹9.33 Lakh | 1.4% | 10.0% | Jaipur, Rajasthan, India | |
| Abv Multispeciality Hospital Private Limited | ₹6.84 Cr (FY 2024) | 50.0% | Faroqnagar, Telangana, India | |||
| Livewell Health Care Private Limited | ₹6.84 Cr (FY 2022) | 155.0% | Hyderabad, Telangana, India | |||
| Southzone Hospitals and Research Centre Private Limited | ₹6.8 Cr (FY 2024) | 22.0% | Kunamkulam, Kerala, India | |||
| Ravi Medical and Research Centre Private Limited | ₹6.79 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Scarlet Formulation Private Limited, buy the company report.
Auditor
Scarlet Formulation Private Limited is audited by JAIN CHOWDHARY & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JAIN CHOWDHARY & CO. | FY 2023 | 113267W |
Shareholding
The shareholding of Scarlet Formulation Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Scarlet Formulation Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Jan 2020 | 100329646 | Hdfc Bank Limited | ₹1 Cr | Open | |
| 31 Oct 2013 | 10459332 | India Infoline Finance Limited | ₹15 Lakh | Open | |
| 30 Sep 2013 | 10459415 | India Infoline Finance Limited | ₹48.63 Lakh | Open | |
| 30 Sep 2013 | 10460451 | India Infoline Finance Limited | ₹9.45 Lakh | Open |
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Scarlet Formulation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Scarlet Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Scarlet Formulation has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAMCS5130Q1ZQ | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Scarlet Formulation Private Limited, buy the company report.
Recent activity
Scarlet Formulation Private Limited has 13 board changes on record since 2008: 8 appointments and 5 cessations. The latest: Kushal Pal Singh was appointed as Director on 25 Nov 2024.
8 earlier events are in the company report.
Frequently asked questions
Scarlet Formulation is an active private limited company based in Jaipur, Rajasthan, India. The company works in hospitals, within the healthcare industry. It was incorporated on 05 November 2008 (18+ years old) and is registered under CIN U24232RJ2008PTC027686.
Scarlet Formulation has 3 current directors:
- Kushal Pal Singh - Director
- Anil Kumar - Director
- Ashwani Kumar Bhatia - Director
The latest financial statements of Scarlet Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Scarlet Formulation is 08AAMCS5130Q1ZQ, registered in Rajasthan. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Scarlet Formulation is U24232RJ2008PTC027686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Scarlet Formulation was incorporated on 05 November 2008, making it 18+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Scarlet Formulation by revenue are Sahayog Hospital and Research Centre Pvt Ltd, Sushma Hospital and Research Centre Private Limited, G L Hospital Private Limited, Abv Multispeciality Hospital Private Limited, Livewell Health Care Private Limited and 2 more, all in the Healthcare industry (Multi Specialty Hospitals), with the same principal business activity (hospital activities).
Kushal Pal Singh was appointed as Director on 25 Nov 2024. Rama Singh ceased to be Director on 21 Oct 2024. Anil Kumar was appointed as Director on 19 Oct 2024. Scarlet Formulation has 13 board changes on record in total.
Yes, Scarlet Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-RJ-17-0023415).
The registered office of Scarlet Formulation is at 62 Panchsheel Enclave Behind Hotel Clark Jln Marg, Jaipur, Rajasthan, India – 302017.
Scarlet Formulation operates in the healthcare industry, in the hospitals segment.

